{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06234462",
            "orgStudyIdInfo": {
                "id": "STU-2023-0234"
            },
            "organization": {
                "fullName": "University of Texas Southwestern Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid",
            "officialTitle": "Feasibility Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid: A Pilot Randomized Control Trial",
            "therapeuticArea": [
                "Rare Diseases",
                "Infectious Diseases"
            ],
            "study": "a-study-of-amantadine-for-cognitive-dysfunction-in-patients-with-long-covid"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-13",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-08",
            "studyFirstSubmitQcDate": "2024-01-29",
            "studyFirstPostDateStruct": {
                "date": "2024-01-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Amy Mathews",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Texas Southwestern Medical Center"
            },
            "leadSponsor": {
                "name": "University of Texas Southwestern Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Purpose: To decrease symptom burden, improve cognitive function, improve endurance, and decrease fatigue in subjects with post-acute sequelae of COVID-19 (PASC) or \"long-hauler\" COVID using amantadine. If amantadine use is determined to be efficacious in this population, the findings of this study will be used towards a subsequent randomized control trial.",
            "detailedDescription": "This study is a prospective, open-label, single-blind, randomized control study. Study duration is approximately 6 weeks starting at the baseline visit. We will recruit 30 participants (15 per arm) for this pilot study."
        },
        "conditionsModule": {
            "conditions": [
                "Long COVID",
                "Post-Acute COVID-19 Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Standard of Care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants in this arm will receive current standard of care for PASC symptoms which may include: PT, OT, SLP, provider counseling, and/or pharmacologic interventions for targeted symptom management.",
                    "interventionNames": [
                        "Other: Physical, Occupational, Speech Therapy",
                        "Other: Provider Counseling",
                        "Other: Medications for symptoms management"
                    ]
                },
                {
                    "label": "Standard of Care + Amantadine",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this arm will review standard of care and amantadine.",
                    "interventionNames": [
                        "Drug: Amantadine",
                        "Other: Physical, Occupational, Speech Therapy",
                        "Other: Provider Counseling",
                        "Other: Medications for symptoms management"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Amantadine",
                    "description": "Participants that have been randomized to the study group will be instructed to begin taking amantadine on the day after this study visit. They will self-administer amantadine 100 mg twice daily (morning and noon) for four weeks",
                    "armGroupLabels": [
                        "Standard of Care + Amantadine"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Physical, Occupational, Speech Therapy",
                    "description": "Physical Therapy (PT) and Occupational Therapy (OT) train patients on breathing exercises and gradual reconditioning. Patients are referred to speech therapy (SLP) for cognitive remediation and metacognitive strategies.",
                    "armGroupLabels": [
                        "Standard of Care",
                        "Standard of Care + Amantadine"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Provider Counseling",
                    "description": "Clinic providers will provide counseling/education on Long-COVID.",
                    "armGroupLabels": [
                        "Standard of Care",
                        "Standard of Care + Amantadine"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Medications for symptoms management",
                    "description": "Clinic providers may recommend targeted pharmacologic management for symptoms the patient is experience. As an example, if a patient reports a headache the provider may recommend over-the-counter or prescription medications to target this particular symptom.",
                    "armGroupLabels": [
                        "Standard of Care",
                        "Standard of Care + Amantadine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Measures of cognitive functioning",
                    "description": "Repeatable Battery for the Assessment of Neuropsychological Status (R BANS) Self-reported percent back to normal, FAS, Trails A\\&B, and Digit\n\nVigilance Test (DVT)",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of cognitive functioning",
                    "description": "Cognitive Subscale of Modified Fatigue Impact Scale (MFIS)",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of cognitive functioning",
                    "description": "Self-reported percent back to normal",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of cognitive functioning",
                    "description": "FAS Test",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of cognitive functioning",
                    "description": "Trails A \\& B",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of cognitive functioning",
                    "description": "Digit Vigilance Test",
                    "timeFrame": "4 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Measures of endurance and strength",
                    "description": "6 Minute Walk Test (6MWT)",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of endurance and strength",
                    "description": "30 second sit-to-stand",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of endurance and strength",
                    "description": "grip strength\n\ngrip strength",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of endurance and strength",
                    "description": "Physical Function subsection of PROMIS-29",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of fatigue",
                    "description": "Physical Subscale of the Modified Fatigue Impact Scale\n\n(MFIS), and fatigue subsection of PROMIS-29.",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Measures of anxiety and depression",
                    "description": "Patient Health Questionnaire-9 (PHQ-9)",
                    "timeFrame": "4-6 weeks"
                },
                {
                    "measure": "Measures of anxiety and depression",
                    "description": "Generalized Anxiety DIsorder-7 (GAD-7) questionnaires",
                    "timeFrame": "4-6 weeks"
                },
                {
                    "measure": "Measures of anxiety and depression",
                    "description": "anxiety and depression sections of the PROMIS-29",
                    "timeFrame": "4-6 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 20-65\n* Can provide informed consent\n* Confirmed COVID+ test (either rapid antigen or PCR) between 8 weeks and one year prior to initial visit.\n* Able to consent in English\n* Endorse symptoms during their initial evaluation and history with the provider that began around the time of the acute COVID19 infection (subjective) including cognitive changes such as cognitive fatigue, brain fog, memory issues,attention issues AND have symptoms in at least 1 out of the 2 following symptom categories:\n* Category 1: Decreased endurance, physical fatigue, weakness\n* Category 2: Depression, anxiety\n\nExclusion Criteria:\n\n* Known hypersensitivity to amantadine\n* Clinically significant psychiatric, neurologic, renal, hepatic, opthalmologic, cardiac impairment in the opinion of the investigators, including but not limited to:\n* Psychiatric:\n* Acute or chronic unstable Axis I psychiatric illness\n* History of psychosis\n* Severe depression Patient Health Questionnaire-9 (PHQ-9) score \\>= 20\n* Suicidality\n* Neurologic:\n* Epilepsy\n* Cognitive dysfunction predating COVID infection\n* History of delirium\n* Neurologic conditions with agitation or confusion",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "20 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Brittany Wright, PhD",
                    "role": "CONTACT",
                    "phone": "469-892-8637",
                    "email": "brittany.wright@utsouthwestern.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Amy Mathews, M.D.",
                    "affiliation": "UT Southwestern Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UT Southwestern Medical Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brittany Wright",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000094024",
                    "term": "Post-Acute COVID-19 Syndrome"
                },
                {
                    "id": "D000060825",
                    "term": "Cognitive Dysfunction"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003072",
                    "term": "Cognition Disorders"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000086382",
                    "term": "COVID-19"
                },
                {
                    "id": "D000011024",
                    "term": "Pneumonia, Viral"
                },
                {
                    "id": "D000011014",
                    "term": "Pneumonia"
                },
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000018352",
                    "term": "Coronavirus Infections"
                },
                {
                    "id": "D000003333",
                    "term": "Coronaviridae Infections"
                },
                {
                    "id": "D000030341",
                    "term": "Nidovirales Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000094025",
                    "term": "Post-Infectious Disorders"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M29705",
                    "name": "Cognitive Dysfunction",
                    "asFound": "Cognitive Dysfunction",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M3013",
                    "name": "Post-Acute COVID-19 Syndrome",
                    "asFound": "Long COVID",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2561",
                    "name": "COVID-19",
                    "relevance": "LOW"
                },
                {
                    "id": "M6301",
                    "name": "Cognition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M13904",
                    "name": "Pneumonia",
                    "relevance": "LOW"
                },
                {
                    "id": "M13914",
                    "name": "Pneumonia, Viral",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20490",
                    "name": "Coronavirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6555",
                    "name": "Coronaviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M23685",
                    "name": "Nidovirales Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3014",
                    "name": "Post-Infectious Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000547",
                    "term": "Amantadine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000978",
                    "term": "Antiparkinson Agents"
                },
                {
                    "id": "D000018726",
                    "term": "Anti-Dyskinesia Agents"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000015259",
                    "term": "Dopamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3888",
                    "name": "Amantadine",
                    "asFound": "Initiative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4295",
                    "name": "Antiparkinson Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7473",
                    "name": "Dopamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M17962",
                    "name": "Dopamine Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "AnDyAg",
                    "name": "Anti-Dyskinesia Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                }
            ]
        }
    },
    "hasResults": false
}